Mono-institutional phase 2 study of innovative Stereotactic Body RadioTherapy targeting PArtial Tumor HYpoxic (SBRT-PATHY) clonogenic cells in unresectable bulky non-small cell lung cancer: profound…

Overview of attention for article published in Radiation Oncology, November 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 35 Dimensions

Readers on

mendeley: 65 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 8 X posts from 7 X users, with an upper bound of 5,981 followers.

RT @radoncpapers: Mono-institutional phase 2 study of innovative Stereotactic Body RadioTherapy targeting PArtial Tumor HYpoxic (SBRT-PATHY…

12 May 2020

Reply Repost Favourite

Mono-institutional phase 2 study of innovative Stereotactic Body RadioTherapy targeting PArtial Tumor HYpoxic (SBRT-PATHY) clonogenic cells in unresectable bulky non-small cell lung cancer: profound non-targeted effects by… https://t.co/ymLFhs7pY1 H/T @NCB

12 May 2020

Reply Repost Favourite

RT @radoncpapers: Mono-institutional phase 2 study of innovative Stereotactic Body RadioTherapy targeting PArtial Tumor HYpoxic (SBRT-PATHY…

01 Dec 2019

Reply Repost Favourite

RT @radoncpapers: Mono-institutional phase 2 study of innovative Stereotactic Body RadioTherapy targeting PArtial Tumor HYpoxic (SBRT-PATHY…

29 Nov 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.